iCAD to Present at the 42nd Annual Cowen Health Care Conference
01 mars 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., March 01, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021
28 févr. 2022 16h05 HE
|
iCAD, Inc.
Launched ProFound AI® Risk, the world’s first clinical decision support tool for short term breast cancer risk estimation Demonstrated compelling survival data for the use of Xoft® Brain IORT in...
iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28
14 févr. 2022 16h05 HE
|
iCAD, Inc.
NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
08 févr. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Feb. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate
24 janv. 2022 14h25 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
iCAD Announces the Appointment of New Members to its Board of Directors
11 janv. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today it has...
iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues
04 janv. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 04, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, reported select...
iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event
23 déc. 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 23, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States
14 déc. 2021 08h00 HE
|
iCAD, Inc.
Treatment marks initiation of international multicenter trial evaluating targeted radiation therapy and bevacizumab for the treatment of the most common and aggressive type of malignant brain tumor ...
iCAD to Participate at the Imagine AI + Healthcare Investor Summit
06 déc. 2021 13h39 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey...